| Accumulation and biological effects of cobalt ferrite nanoparticles in human pancreatic and ovarian cancer cells V Pašukonienė, A Mlynska, S Steponkienė, V Poderys, M Matulionytė, ... Medicina 50 (4), 237-244, 2014 | 58 | 2014 |
| Xenogeneic therapeutic cancer vaccines as breakers of immune tolerance for clinical application: to use or not to use? MM Strioga, A Darinskas, V Pasukoniene, A Mlynska, V Ostapenko, ... Vaccine 32 (32), 4015-4024, 2014 | 41 | 2014 |
| Tumor lysate-loaded Bacterial Ghosts as a tool for optimized production of therapeutic dendritic cell-based cancer vaccines N Dobrovolskienė, V Pašukonienė, A Darinskas, JA Kraśko, K Žilionytė, ... Vaccine 36 (29), 4171-4180, 2018 | 37 | 2018 |
| A gene signature for immune subtyping of desert, excluded, and inflamed ovarian tumors A Mlynska, R Vaišnorė, V Rafanavičius, S Jocys, J Janeiko, M Petrauskytė, ... American Journal of Reproductive Immunology 84 (1), e13244, 2020 | 29 | 2020 |
| Chemokine profiling in serum from patients with ovarian cancer reveals candidate biomarkers for recurrence and immune infiltration A Mlynska, G Salciuniene, K Zilionyte, S Garberyte, M Strioga, B Intaite, ... Oncology reports 41 (2), 1238-1252, 2019 | 22 | 2019 |
| Platinum sensitivity of ovarian cancer cells does not influence their ability to induce M2‐type macrophage polarization A Mlynska, E Povilaityte, I Zemleckaite, K Zilionyte, M Strioga, J Krasko, ... American Journal of Reproductive Immunology 80 (3), e12996, 2018 | 15 | 2018 |
| Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 … K Žilionytė, U Bagdzevičiūtė, A Mlynska, E Urbštaitė, E Paberalė, ... Cancer Immunology, Immunotherapy 71 (11), 2691-2700, 2022 | 8 | 2022 |
| Post-operative unadjuvanted therapeutic xenovaccination with chicken whole embryo vaccine suppresses distant micrometastases and prolongs survival in a murine Lewis lung … JA Kraśko, K Žilionytė, A Darinskas, N Dobrovolskienė, A Mlynska, ... Oncology Letters 15 (4), 5098-5104, 2018 | 7 | 2018 |
| Evaluation of low-dose proton beam radiation efficiency in MIA PaCa-2 pancreatic cancer cell line vitality and H2AX formation A Liubavičiūtė, JA Kraśko, A Mlynska, J Lagzdina, K Sužiedėlis, ... Medicina 51 (5), 302-306, 2015 | 7 | 2015 |
| Immunophenotype rearrangement in response to tumor excision may be related to the risk of biochemical recurrence in prostate cancer patients P Bosas, G Zaleskis, D Dabkevičiene, N Dobrovolskiene, A Mlynska, ... Journal of Clinical Medicine 10 (16), 3709, 2021 | 4 | 2021 |
| Correction to: Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in … K Žilionytė, U Bagdzevičiūtė, A Mlynska, E Urbštaitė, E Paberalė, ... Cancer Immunology, Immunotherapy: CII 71 (11), 2701, 2022 | 2 | 2022 |
| Immunomodulatory properties of bacteriophage derived dsRNA of different size and their use as anticancer vaccine adjuvants N Dobrovolskienė, R Balevičius, A Mlynska, K Žilionytė, JA Krasko, ... Vaccine 42 (3), 512-521, 2024 | 1 | 2024 |
| The role of systemic and local immunity in tumor development and response to treatment A Mlynska Vilniaus universitetas., 2018 | 1 | 2018 |
| From sweat to hope: The role of exercise‐induced extracellular vesicles in cancer prevention and treatment A Llorente, A Brokāne, A Mlynska, M Puurand, K Sagini, S Folkmane, ... Journal of Extracellular Vesicles 13 (8), e12500, 2024 | | 2024 |
| Prognostic significance of soluble PD-L1 in prostate cancer M Zvirble, Z Survila, P Bosas, N Dobrovolskiene, A Mlynska, G Zaleskis, ... Frontiers in Immunology 15, 1401097, 2024 | | 2024 |
| Defining Melanoma Immune Biomarkers—Desert, Excluded, and Inflamed Subtypes—Using a Gene Expression Classifier Reflecting Intratumoral Immune Response and Stromal Patterns A Mlynska, J Gibavičienė, O Kutanovaitė, L Senkus, J Mažeikaitė, ... Biomolecules 14 (2), 171, 2024 | | 2024 |
| Accumulation of quantum dots and chlorin e6 complex in distinct phenotypes of human colon cancer cells E Pečiukaitytė, E Voronovič, A Butkutė, A Mlynska, S Steponkienė, ... 3rd Baltic biophysics conference: October 6-7, 2022, Vilnius, Lithuania …, 2022 | | 2022 |
| Molecular biomakers of mouse tumor immunogenicity and prediction of response to dendritic cell vaccines and anti‐PD‐1 treatment K Žilionytė, U Bagdzevičiūtė, A Mlynska, E Urbštaitė, E Paberalė, ... Wiley-VCH Verlag GmbH & Co. KGaA, 2021 | | 2021 |
| The evaluation of immunogenic and tolerogenic gene expression with different length Larifan fractions matured dendritic cell N Dobrovolskienė, A Mlynska, K Žilionytė, V Pašukonienė, R Balevičius, ... Wiley-VCH Verlag GmbH & Co, 2021 | | 2021 |
| Targeting the immunomodulatory properties of stem‐like colorectal cancer cell lines A Mlynska, A Butkutė, M Baltramonaitis, S Skiotytė, K Žilionytė, ... Wiley-VCH Verlag GmbH & Cov, 2021 | | 2021 |
